Right now, tens of millions of Americans living with diabetes have better access to life-saving medication. Drug maker Eli Lilly slashed prices of its most commonly prescribed insulin products. Lilly said it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter – which starts in October. MORE: https://bit.ly/3EN7Cjt ►Subscribe: https://on.wtsp.com/youtube ►Website: https://www.wtsp.com/ ►Facebook: https://facebook.com/10TampaBay ►Twitter: https://twitter.com/10TampaBay